MedTrace Logo

Using mHealth to Optimize Pharmacotherapy Regimens

NCT04248517 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2026-07-13

No results posted yet for this study

Summary

This project will use a smartphone technology to improve medication prescribing for individuals with FEP. We will collect real-time symptom and functioning data via smartphones to provide prescribers and other clinical team members with clinically relevant and time-sensitive information that will inform and promote shared decision making (SDM) and personalized interventions. The result will be a time-sensitive, data-driven, collaborative process to optimize medication regimens in order to maximize benefits, minimize harms, and promote adherence.

Data collection for NCT04248517 (Using mHealth to Optimize Pharmacotherapy Regimens) was completed in December 2023. Data analysis was underway when human subjects research at NYSPI was suspended on June 23, 2023 and thus study results are not available to be posted. The team will post results as soon as possible.

Conditions

Interventions

OTHER

mHealth Intervention

Participants will download the app onto their smartphone and complete ecological momentary assessements

Sponsors & Collaborators

  • Northwell Health, Early Treatment Program at Lenox Hill

    collaborator UNKNOWN

  • The Institute for Family Health Center for Counseling at Walton

    collaborator UNKNOWN

  • New York State Psychiatric Institute, Washington Heights Community Service

    collaborator UNKNOWN

  • BestSelf Behavioral Health

    collaborator UNKNOWN

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Scott Stroup, MD, MPH · New York State Psychiatric Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-09
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04248517 on ClinicalTrials.gov